Clinical Trials Directory

Trials / Conditions / Glucagon-like Peptide-1

Glucagon-like Peptide-1

9 registered clinical trials studyying Glucagon-like Peptide-1.

StatusTrialSponsorPhase
CompletedGastric Ultrasound Assessment for Patients Taking GLP1 Agonists
NCT06003985
Hospital for Special Surgery, New York—
CompletedEffects of GLP-1 Agonists on Gastric Volume
NCT05854979
Medical University of South Carolina—
CompletedSmoking Cessation Facilitated by Glucagon-like Peptide-1 (GLP-1) Analogues
NCT03204396
University Hospital, Basel, SwitzerlandPhase 2
UnknownPlasma GLP1 and Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
NCT02846168
Chinese PLA General Hospital—
CompletedEffect of LIXIsenatide on the Renal System
NCT02276196
Amsterdam UMC, location VUmcPhase 4
CompletedPlasma Glucagon-like Peptide-1 Levels and In-hospital Complications in ST-segment Elevation Myocardial Infarct
NCT03314844
Chinese PLA General Hospital—
CompletedPlasma Glucagon-like Peptide-1 Levels and Acute Myocardial Infarction
NCT03129594
Chinese PLA General Hospital—
CompletedVasodilatory and Metabolic Effects of Glucagon-like Peptide-1 in Periphery Circulation in Patients With and Wi
NCT01689051
University Hospital, Gentofte, CopenhagenN/A
CompletedEffects of Exendin(9-39) on Gastroduodenal Motility
NCT00468091
Ludwig-Maximilians - University of MunichPhase 1